Authored by: Katherine Houlihan, PharmD, CDOE
Register – $7.00Overview
Currently, the American Association for the Study of Liver Diseases (AASLD) guidelines recommend screening for high-risk hepatitis B antigen carriers rather than all patients with HBV infection for hepatitis delta, although studies suggest HDV screening is rarely implemented.
The goal of this continuing education home study is to increase awareness of hepatitis delta, common signs and symptoms for clinicians to identify, and common risk factors. It is also to inform clinicians on the appropriate screening and treatment recommendations for this population, and the associated adverse effects associated with treatment.
This program will be delivered online via Articulate.
Target Audience
Pharmacists in all practice settings.
Learning Objectives
Upon completion of this educational activity, participants will be able to:
- List or identify patient-specific risk factors for contracting hepatitis delta
- Breakdown screening recommendations and requirements for diagnosis for patients at risk of hepatitis delta
- Develop patient-centered goals of therapy in those diagnosed with hepatitis delta
- Choose an optimal treatment regimen for viral suppression in patients with hepatitis delta, including dose, frequency, and duration, and determine appropriate post-treatment monitoring
Technology
A mobile device or computer with an internet connection is required.
Author
Requirements for Credit
Completion of the online educational activity and a program evaluation are required to earn credit. No partial credit is available for this program. Evaluations must be completed at www.uripharmacycpd.org within 60 days.
Evaluation
All participants will have the opportunity to review the educational sessions and speakers and to identify future educational needs.
Registration
The accreditation service fee for this program is $7.00
- Login or create an account in URI’s learning management and CE reporting system using your email address and professional license number. Complete all required account set up fields to ensure accurate CE reporting.
- Select “Available On-Line Activities” or “Home Study Programs” to find the educational activity.
- Select Take Post-Test and proceed to secure online payment (Visa, MC, AMEX, Discover or Electronic Checks accepted).
Statement of Disclosure
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Standards for Continuing Pharmacy Education, The University of Rhode Island College of Pharmacy requires that program faculty disclose any relationship (e.g., shareholder, recipient of research grant, consultant or member of an advisory committee) that the faculty may have with ineligible companies whose products or services may be mentioned in their presentations. No one involved in the planning of this program has any relevant financial relationships to disclose.